Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies
- PMID: 16720822
- DOI: 10.1001/jama.295.20.2366
Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies
Abstract
Context: Limited evidence exists to guide the optimal frequency of repeat endoscopic examination for colorectal cancer screening after a negative colonoscopy.
Objective: To determine the duration and magnitude of the risk of developing colorectal cancer following performance of a negative colonoscopy.
Design, setting, and patients: Population-based retrospective analysis of individuals whose colonoscopy evaluations did not result in a diagnosis of colorectal neoplasia. Patients who had been evaluated between April 1, 1989, and December 31, 2003, were identified using Manitoba Health's physician billing claims database (N = 35 975). Standardized incidence ratios (SIRs) were calculated to compare colorectal cancer incidence in our cohort with colorectal cancer incidence in the provincial population. Stratified analysis was performed to determine the duration of the reduced risk. Patients with a history of colorectal cancer prior to the index colonoscopy, inflammatory bowel disease, resective colorectal surgery, and lower gastrointestinal endoscopy within the 5 years before the index colonoscopy were excluded. Cohort members were followed up from the time of the index colonoscopy until diagnosis of colorectal cancer, death, out-migration from Manitoba, or end of the study period on December 31, 2003.
Main outcome measure: Incidence of colorectal cancer.
Results: A negative colonoscopy was associated with SIRs of 0.69 (95% confidence interval [CI], 0.59-0.81) at 6 months, 0.66 (95% CI, 0.56-0.78) at 1 year, 0.59 (95% CI, 0.48-0.72) at 2 years, 0.55 (95% CI, 0.41-0.73) at 5 years, and 0.28 (95% CI, 0.09-0.65) at 10 years. The proportion of colorectal cancer located in the right side of the colon was significantly higher in the colonoscopy cohort than the rate in the Manitoba population (47% vs 28%; P<.001).
Conclusions: The risk of developing colorectal cancer remains decreased for more than 10 years following the performance of a negative colonoscopy. There is a need to improve the early detection rate of right-sided colorectal neoplasia in usual clinical practice.
Comment in
-
Screening for colorectal cancer by colonoscopy: adding to the evidence.JAMA. 2006 May 24;295(20):2411-2. doi: 10.1001/jama.295.20.2411. JAMA. 2006. PMID: 16720827 No abstract available.
-
Colorectal cancer risk following a negative colonoscopy.JAMA. 2006 Nov 22;296(20):2436-7; author reply 2437-8. doi: 10.1001/jama.296.20.2436-b. JAMA. 2006. PMID: 17119135 No abstract available.
-
Colorectal cancer risk following a negative colonoscopy.JAMA. 2006 Nov 22;296(20):2437; author reply 2437-8. doi: 10.1001/jama.296.20.2437-a. JAMA. 2006. PMID: 17119136 No abstract available.
-
Screening colonoscopy: the benefits are durable, but are they as great as we thought?Gastroenterology. 2006 Dec;131(6):2016-8; discussion 2018. doi: 10.1053/j.gastro.2006.10.056. Gastroenterology. 2006. PMID: 17188965 No abstract available.
Similar articles
-
Predictors of colorectal cancer after negative colonoscopy: a population-based study.Am J Gastroenterol. 2010 Mar;105(3):663-73; quiz 674. doi: 10.1038/ajg.2009.650. Epub 2009 Nov 10. Am J Gastroenterol. 2010. PMID: 19904239
-
Long-Term Colorectal Cancer Incidence After Negative Colonoscopy in the State of Utah: The Effect of Family History.Am J Gastroenterol. 2017 Sep;112(9):1439-1447. doi: 10.1038/ajg.2017.193. Epub 2017 Jul 11. Am J Gastroenterol. 2017. PMID: 28695908
-
Time trends in colon cancer incidence and distribution and lower gastrointestinal endoscopy utilization in Manitoba.Am J Gastroenterol. 2008 May;103(5):1249-56. doi: 10.1111/j.1572-0241.2007.01726.x. Epub 2008 Jan 11. Am J Gastroenterol. 2008. PMID: 18190650
-
Sex- and gender-specific disparities in colorectal cancer risk.World J Gastroenterol. 2015 May 7;21(17):5167-75. doi: 10.3748/wjg.v21.i17.5167. World J Gastroenterol. 2015. PMID: 25954090 Free PMC article. Review.
-
Estimating the Effect of Targeted Screening Strategies: An Application to Colonoscopy and Colorectal Cancer.Epidemiology. 2017 Jul;28(4):470-478. doi: 10.1097/EDE.0000000000000668. Epidemiology. 2017. PMID: 28368944 Free PMC article. Review.
Cited by
-
The Innate Immune System Surveillance Biomarker p87 in African Americans and Caucasians with Small High-Grade Dysplastic Adenoma [SHiGDA] and Right-Sided JAK3 Colon Mutations May Explain the Presence of Multiple Cancers Revealing an Important Minority of Patients with JAK3 Mutations and Colorectal Neoplasia.Gastrointest Disord (Basel). 2024 Jun 7;6(2):497-512. doi: 10.3390/gidisord6020034. Gastrointest Disord (Basel). 2024. PMID: 39507544 Free PMC article.
-
Impact of the serrated pathway on the simulated comparative effectiveness of colorectal cancer screening tests.JNCI Cancer Spectr. 2024 Sep 2;8(5):pkae077. doi: 10.1093/jncics/pkae077. JNCI Cancer Spectr. 2024. PMID: 39240660 Free PMC article.
-
The durability of previous examinations for cancer: Danish nationwide cohort study.Scand J Prim Health Care. 2024 Jun;42(2):246-253. doi: 10.1080/02813432.2024.2305942. Epub 2024 Jan 22. Scand J Prim Health Care. 2024. PMID: 38251839 Free PMC article.
-
Epidemiology and early screening strategies for colorectal cancer in China.Chin J Cancer Res. 2023 Dec 30;35(6):606-617. doi: 10.21147/j.issn.1000-9604.2023.06.05. Chin J Cancer Res. 2023. PMID: 38204448 Free PMC article.
-
Linked color imaging versus white light imaging in the diagnosis of colorectal lesions: a meta-analysis of randomized controlled trials.Therap Adv Gastroenterol. 2023 Oct 4;16:17562848231196636. doi: 10.1177/17562848231196636. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37810280 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
